Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “RA PHARMACEUTICALS, INC.”

115 pharma patents match "RA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 115
Index total 30,257
Page 4 / 5

Quick answer

This filtered view shows 115 pharmaceutical patents matching "RA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

115 results for “RA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 9808424

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  2. US 9770414

    Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

    Pacira Pharmaceuticals, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  3. US 9757336

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  4. US 9737483

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  5. US 9737482

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  6. US 9730892

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

  7. US 9724302

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  8. US 9644004

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted May 9, 2017 · Expires May 4, 2037

    granted

  9. US 9624182

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  10. US 9585838

    Production of multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted

  11. US 9556133

    Polycyclic LPA1 antagonist and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  12. US 9272990

    Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis

    AMIRA PHARMACEUTICALS, INC. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  13. US 9260416

    Heterocyclic autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  14. US 9238676

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  15. US 9205052

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  16. US 9192575

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  17. US 9090573

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  18. US 9000025

    Autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  19. US 8834921

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  20. US 8778983

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  21. US 8664220

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  22. US 8592402

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  23. US 8541587

    Lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  24. US 8455499

    Alkyne antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.